Three Calls, One Misunderstanding: What treament Is Actually Like

People tend to imagine medical cannabis in extremes.

On one end: a cynical shortcut — a legal pathway for people chasing a cheap thrill, a “soft option” for those who don’t want to do the hard work of health. On the other: a miracle cure, sold with glossy certainty, as if a plant could tidy up life’s mess.

Neither picture survives contact with a real clinic day.

Because what comes through a cannabis clinician’s door — or, more often now, over the phone — is not a subculture. It’s a cross-section. People from farms and suburbs, older and younger, stable and unraveling, polite and exhausted. People who have tried the respectable pathways, ticked the boxes, swallowed the pills, done the scans, seen the specialists — and still wake up in pain, or can’t sleep, or can’t function in the way they used to.

And the quiet truth is this: the consultations aren’t mainly about cannabis.

They’re about what happens to a person when illness, pain, stress, injury, or trauma takes away their normal tools for coping — and they’re trying, imperfectly, to remain a functioning human being.

The farmer, the foot, and the year that took everything

The first call that day comes from far out of town. You can hear the distance in the way he speaks: the practical language of someone who lives with problems that have to be solved, because there’s no one around to solve them for you.

He’s in his mid-60s and he’s been battling a serious foot injury for over a year — surgery, infection, setbacks, antibiotics, the kind of stop-start recovery that turns months into a calendar you dread. He’s trying to walk again now, in a moon boot, with a stick, and it’s painful in a way people underestimate. Swelling isn’t cosmetic; it’s pressure, nerves, relentless tenderness — the body punishing you for doing what you’re told is “rehabilitation.”

He admits what most patients in long recoveries eventually admit: he overdoes it. Not because he’s reckless, but because “rest” is not a skill he’s practised. He’s a working man, used to getting up and doing things. Now, simply standing in the yard can mean hours of throbbing afterwards.

Then, as often happens in these conversations, the medicine becomes inseparable from the rest of life.

He’s under financial pressure. A year off work has a way of squeezing everything. He’s waiting on disability support decisions and juggling the cost of living, the cost of care, the cost of simply staying afloat. There’s an almost offhand mention of a thousand-dollar vet bill — the kind of casual hit that people on the edge can’t just absorb and move on, but that’s just one problem among many.

And then he mentions his teeth. All his bottom teeth were lost in the accident. It affects what he can eat, but also what he feels he can be. He talks about the humiliation of it — not melodramatically, just plainly — how it steals confidence, how it makes you feel less human, less worthy of normal life. He talks about overseas dental care because in Australia the prices and wait times feel impossible.

This is where the stereotype collapses. This isn’t a person chasing a high. This is a person trying to remain upright — physically, financially, emotionally.

When cannabis comes up, it comes up like any other medication in complex chronic illness: as a compromise. It helps pain. It helps him get through the day. But he’s worried about his lungs, about coughing, about the long-term cost of smoking. He doesn’t smoke cigarettes; this isn’t the familiar narrative of self-destruction. It’s someone noticing his body warning him and asking how to do better.

So the conversation becomes harm reduction in its most ordinary form: shifting away from inhalation, exploring oral forms, finding ways to make treatment sustainable. It also becomes self-care advice in a way that would be familiar to anyone in chronic pain management: compression for swelling, pacing, not letting the push-through instinct undo months of progress.

The consultation ends, not with a sales pitch, but with something much less fashionable and far more real: encouragement to keep going, and a plan that tries to keep the next three months manageable.

The woman with double vision and the exhaustion of “nothing found”

The second call is different: a woman whose main complaint isn’t pain, but double vision — years of it — and the kind of frustration that only comes from navigating a system that keeps asking you to start again.

She’s had scans. She’s seen ophthalmologists and an ENT and a neurologist. She’s had surgeries for other issues along the way — gallbladder, sinuses — and she’s had more than one MRI reported as normal. Nothing ominous. Nothing obvious. Which is both reassuring and maddening.

She describes how it affects her: bright shopping centres, crowded environments, anything visually busy becomes exhausting. She tilts her head to compensate. She closes one eye to function. It strains her neck, then her back, then her whole day.

People can be surprisingly dismissive of symptoms that don’t look dramatic. Double vision isn’t glamorous; it doesn’t fit neatly into a single diagnosis. But it is a constant drain on attention and energy — and when you’re tired enough, the world becomes hostile.

Her cannabis use is modest, stable, almost boring: a few puffs at night to help sleep and settle her mind. She says it has helped her mental health. She feels happier. The pattern is consistent. There is no chaos, no escalation, no sense of “chasing.”

This is another point where preconceptions fail.

When some people hear “medical cannabis,” they imagine intoxication as the goal. In practice, many patients are using it like they use any evening medication: to reduce the friction of a body or brain that won’t let them rest. Sleep is not a luxury in chronic illness. It’s a foundation stone.

So the role of the clinician here is not to pretend cannabis solves the double vision. It doesn’t. The clinician’s role is to keep one part of the patient’s life steadier — sleep, mood, the capacity to cope — while the unresolved clinical problem continues to be pursued through mainstream pathways.

That, too, is medicine. Not dramatic, not headline-friendly, but essential.

The young father who knows exactly what relapse looks like

The third call comes from a man in his early adult years who asks to change one product on his script. One of his flower products isn’t working as well anymore; he wants something with a similar strength to the one he finds effective.

Again, this is where people outside the work often misread the scene. They imagine it’s about potency, preference, a kind of consumer shopping.

But then the real reason the call matters emerges: he’s under serious stress. His ex partner and their toddler are facing housing instability. He’s trying to help, trying to provide some stability, trying to do the right thing in a situation where every option comes with emotional cost.

He also discloses something that, in many settings, still carries shame: a past methamphetamine addiction that cost him his home and his family life. He speaks about it without excuses. He names his mistakes. He describes what he’s trying to do now: maintain co-parenting, stay steady, not go back to the person he used to be.

In a clinic like this, addiction history isn’t a scandal. It’s a risk factor. It’s a reality. It’s a part of the story that has to be held with respect and caution. So the conversation becomes what good medicine often becomes: not just “here is the thing you asked for,” but “how are you holding up?”

Because in real life, people relapse — not because they’re morally weak, but because stress compresses the mind until old coping strategies start calling again. Sometimes what prevents that isn’t a lecture. It’s being seen. Being spoken to as a whole person. Being reminded that there are choices still available.

The prescription change happens, but it happens within boundaries: options are provided without opening the floodgates; the goal is symptom control without loss of control.

And the emotional centre of the consult isn’t cannabis at all.

It’s a man trying to stay human in a moment when life is trying to knock him sideways.

What this work reveals about medicine’s blind spots

These three people have almost nothing in common on paper. Different ages. Different lives. Different problems. Different relationships to health and identity.

They do, however, share something that is quietly common in chronic illness and long-term distress:

They’re trying to stay functional when there is no clean solution.

Modern medicine is astonishing at certain things: infection control, trauma surgery, acute intervention, lifesaving treatment. But it is often uncomfortable in the grey zones — the long tail of pain, insomnia, grief, disability, “medically unexplained” symptoms, slow recovery, mental strain, the life consequences of illness.

These are domains where people can feel reduced to scan results and medication lists. Where “nothing serious found” can translate to “nothing we can do.” Where a person’s hopes start to feel embarrassing — as if wanting a better life is a naïve request rather than a legitimate clinical consideration.

Cannabis medicine, as an emerging field, sits directly in those grey zones. That is one reason it makes people uneasy. It hasn’t had decades to become culturally ordinary. It carries stigma. It carries a history of misuse, and that history leaks into every conversation.

But it also arrives in a part of healthcare where the old tools don’t always work — or work only partially — and where “evidence-based” can sometimes mean “evidence for what we measure,” rather than “evidence for what people actually need."

What cannabis treatment sometimes offers is not a cure. It offers a tool — often imperfect — that can reduce suffering enough for someone to take the next step: to sleep, to mobilise, to parent, to cope, to hold onto dignity. And once a clinician has that foothold, the consult can widen into the bigger work: self care strategies, pacing, respiratory harm reduction, mental health support, life direction, relationship boundaries, practical planning.

It’s not that cannabis clinics are uniquely compassionate. It’s that the patients who arrive at them often need the sort of care that requires compassion as a baseline — because the rest of the system, by necessity or by culture, often focuses on what can be tested, measured, ruled out, or treated quickly.

The real story behind the stigma

If you want to understand medical cannabis prescribing, forget the stereotypes.

Most patients aren’t seeking cheap thrills. They’re seeking sleep. Relief. Function. A way to be present in their own lives when pain or anxiety or stress would otherwise hollow the day out.

And the clinician’s job isn’t to hand over a product like a commodity.

It’s to assess, to set limits, to reduce harm, to monitor patterns, to balance risks, and — crucially — to meet the human being on the other end of the line as a human being. To take seriously the emotional requirements of chronic illness: the need for hope, for dignity, for being believed, for having some tool available when the cupboard is otherwise bare.

On paper, these three calls could be summarised as “follow-up scripts.” In real life, they are what much of modern healthcare actually is: people bringing the wreckage and the resilience of their lives to a clinician, and trying to find a way — not to feel great — but to keep going.

And sometimes, in that narrow but vital space, cannabis is simply one of the tools that makes “keep going” possible.